A novel system design based on more than 10 years of extensive work. Several iterations, proven by clinical studies, have led to a ground-breaking, non-invasive glucose monitoring system.
Our advanced technology uses Raman Spectroscopy to measure glucose in the interstitial fluid without a blood sample.
We achieve this by shining a laser at the molecules, including glucose, in the interstitial fluid, and measuring the frequency change of the returning light.
RSP Systems holds several patents. Among these, our patented Critical Depth technology enables us to improve the signal-to-noise ratio, thereby enabling our state-of-the-art accuracy for glucose measurement.
Our advanced AI algorithm, constantly improved through 19 clinical studies with a total of over 700 participants, pin-points glucose data in our measurements, enabling our state-of-the-art Touch Glucose Monitoring system.
Developing GlucoBeam™ has given us extensive knowledge and the needed resources to further develop our technology. This will allow us to bring the technology to the masses, giving people worldwide important insight to their state of health. We are on a journey to miniaturize, improve accuracy, reduce costs, and provide information about health vitals of many kinds.
Our Vision
Our goal is to make glucose monitoring so unintrusive that it sets a new standard of care.
We strive to improve access to health information through glucose measurement, for all people who can benefit from understanding their glucose level.
Quicklinks
Contact
